Current status of pharmacist influences on prescribing of medicines
|
|
- Josephine Carr
- 5 years ago
- Views:
Transcription
1 Current status of pharmacist influences on prescribing of medicines Lisa Nissen Am J Health-Syst Pharm. 2009; 66(Suppl 3):S29-34 Chemists, druggists, and apothecaries historically were tradespeople who performed similar tasks. Eventually, apothecaries split from the chemists and druggists to become general practitioners, while the other two groups combined to become pharmacists. 1 Looking back at the of pharmacy as a profession, we can see whence we came and where we are going may well be the same place. However, the question of what constitutes prescribing must first be answered in order to evaluate how pharmacists in a variety of practice situations can influence prescribing to improve patient outcomes. If pharmacists become prescribers, they will be subjected to the same influences as any other prescriber. The processes of prescribing can be expanded from the basic process given by the World Health Organization (WHO). 2 Influence of pharmacists on prescribing practices The influence of pharmacists on prescribing practices can be seen daily in any conceivable practice situation. No health professional is infallible, and the benefits of a variety of clinical pharmacist interventions have been documented. 3-9 Some interventions or influences that may seem simple and mundane in advanced health systems such as those in Europe, the United States, or Australia (e.g., medication counseling 4,5 or taking an admission drug history) 3,4 may produce a major improvement in a developing nation. Indeed, pharmacists should focus on the diseases where they can have the greatest impact in their local environment. For example, this could involve human immunodeficiency virus (HIV) and tuberculosis in developing countries, while developed countries may focus on diabetes, hypertension, and hyperlipidemia. Clinical pharmacy practice has developed internationally to expand the role of a pharmacist well beyond the traditional roles of compounding and supplying drugs. However, not all countries have the resources to provide these high-level services immediately or train their pharmacists in the requisite skills. Pharmacists, especially those working in the hospital environment, must often prioritize their time and resources to optimize patient outcomes with limited resources. The level of resources available differs greatly between countries and their respective health systems. For example, providing one pharmacist with entry-level qualifications to a major city hospital in a developed country may not affect regular service delivery, but the same pharmacist in a developing nation may be the only pharmacist in the hospital and provide a major improvement in pharmacy services. Such comparisons build the continuum of pharmacist services based on availability and complexity of service level able to be delivered (Table 1). However, prescribing can be influenced at all points along this continuum and at varying levels, depending on the resources and training available. Formulary WHO produced the first model list of essential drugs, or suggested formulary for developing nations, in It was then estimated that 12 countries had such a list of drugs; in 2003, this number had grown to over 100. Linking these formularies with standard treatment guidelines (also a role of formularies) has been shown to improve patient outcomes. In other cases, drugs are included on a formulary because clinical guidelines recommend the drug. The existence Lisa Nissen, B.Pharm., Ph.D., is Senior Lecturer, School of Pharmacy, The University of Queensland, St. Lucia, Queensland 4072, Australia (l.nissen@uq.edu.au). Dr. Nissen received an honorarium from the International Pharmaceutical Federation for preparing this article and acting as a working-group facilitator. Copyright 2009, American Society of Health-System Pharmacists, Inc., and International Pharmaceutical Federation. All rights reserved /09/0301-0S29$ DOI /ajhp Am J Health-Syst Pharm Vol 66 Mar 1, 2009 Suppl 3 S29
2 of formularies provides a standard for practice where compliance promotes patient outcomes, especially in developing nations. 11 Formularies are also effective in the developed world, where 98% of European hospitals have a drug & therapeutics committee and 95% have pharmacy representation. An average of 1031 drug products and 694 chemical entities are listed on formularies across Europe, with an Table 1. Continuum of Pharmacist Practice Activity Foundational Intermediate (Foundational Plus...) Formulary committees must have at least 1pharmacist as a full voting member. Advanced (Intermediate Plus...) Formulary Logistics of pharmaceutical supply chain Prescriber Drug order Participation in patient rounds Pharmacist prescribing Hospitals should utilize a drug formulary (local, regional, national) based on the best available evidence; formulary committees must include the person responsible for drug procurement. A dedicated person (who may not be a pharmacist) should control all drug related logistics for each hospital. Pharmacists should provide and discuss formulary information with prescribers. A pharmacist should be available (whether on-site or remote) to provide a drug order for patients. Each ward should have a dedicated pharmacist (whether onsite or remote) as a point of contact; pharmacy technicians could be trained to take medication histories.... Pharmacists should oversee all drug related logistics for each hospital; however, pharmacist may not perform drug-related logistics tasks. Pharmacists should actively educate prescribers about formulary information and restrictions. A pharmacist drug order should be provided to each patient. Pharmacists should be present during patient rounds to assist with pharmacy issues.... A multidisciplinary committee with pharmacist input in the process should each formulary request to provide a balanced overview of the evidence and pharmacoeconomic issues for each drug. Pharmacists should control all drugrelated logistics for each hospital. A dedicated pharmacist-run drug information center with facilities to research complex clinical questions and educate prescribers about quality use of medicines. Pharmacists should be encouraged to complete postgraduate study in relevant clinical areas; specialist pharmacists in high-risk areas (e.g., oncology, pediatrics) should dose calculations and advise on drug protocol. Pharmacists should be an integral part of each patient round to assist with therapeutic decision-making and advise on clinical pharmacy issues; pharmacy technicians should be appropriately trained to check dispensed products to free pharmacist time; specialist pharmacists in high-risk areas (e.g., oncology, pediatrics) should be present at each patient round or clinic group meeting. Specific postgraduate clinical courses should be developed to prepare pharmacists for prescribing medications; systemwide curricula should be developed embracing pharmacist therapeutic decisionmaking (prescribing). S30 Am J Health-Syst Pharm Vol 66 Mar 1, 2009 Suppl 3
3 increasing number of hospitals having a formulary. 12 European drug formularies contain some or all of the following to encourage appropriate and rational drug use: Hospital drug-use policy, Dosage or prescribing information, Drug price information, Antibiotic prescribing protocols (treating infections), Antibiotic prescribing protocols (surgical prophylaxis), and Local antibiotic susceptibility. The American Society of Health- System Pharmacists (ASHP) recommends a formulary system to ensure high-quality and cost-effective drug therapy, with the drugs considered by a multidisciplinary committee to be the most useful in patient care. 13 Pharmacists are considered essential members of this committee and can provide advice to reconcile cost implications with evidence tailored to improve patient outcomes. Indeed, the Global Pharmacy Survey, which collects a single-point estimate of hospital pharmacy practice, indicated that formularies are required in many countries across the developed and developing world. Logistics of the pharmaceutical supply chain Unqualified suppliers of medicines or other employees often provide logistics services; however, a pharmacist should be available for consultation at a minimum. Nonpharmacists have these roles in small rural and remote hospitals in developed countries such as Australia, albeit within a national, state, or regional hospital formulary. However, even within a formulary, the major implication of nonpharmacist staff controlling logistics is a lack of understanding of the properties of the drugs, leading to a perception that pharmaceuticals are just another stored item, and consequent inappropriate logistics management. This can lead to inappropriate prescribing, since prescribers will often base their drug choice on the drugs in stock if the drug of choice is not available. 14 Pharmacists should oversee logistics (even remotely) to ensure appropriate inventories are maintained to meet formulary guidelines and local conditions in collaboration with local prescribers. Pharmacists can therefore assist in informing the specifications for a local formulary as a subset of the systemwide formulary by providing ongoing appraisal and of prescribing trends based on inventory requests. Prescriber Since European drug formularies contain some or all of the hospital policies on drug-use and drug restrictions, 12 they provide an excellent basis for pharmacists to educate prescribers about rational drug therapy. This will influence the prescribers drug choices, either directly or indirectly, through increased awareness of the hospital s policies. Such strategies have also proven effective in developing countries such as Sri Lanka, where prescriber about formulary restrictions produced improvements in formulary compliance. 11 The Society of Hospital Pharmacists of Australia (SHPA) practice standards specify that the provision of and training to other health professionals is an important aspect of a clinical pharmacist s role. 15 It is also instrumental to increasing the pharmacists profile. Academic detailing and other al interventions by pharmacists have been shown to reduce prescribing and drug costs through physician. 16,17 Correspondents from developing countries bemoan the difficulty of embracing evidence-based practice and suggest it is due to low levels of medical research and the consequent low priority for maintaining current knowledge. 18 Such problems may be a systematic issue, in which practitioners are busy treating patients and have little time for reading and maintaining knowledge currency. This is an area where pharmacistprovided sessions could distill new s into current local practice, thereby influencing prescribing practices. Prescribers should also be educated about the role of pharmacists in health care decision-making. As shown above, clinical pharmacy services improve patient and financial outcomes 3,9 yet can be ignored by clinical experts. The role of the pharmacist as an integral part of the health care team should be promoted, especially in areas of chronic high incidence diseases and emerging diseases. Drug information can also play an important role in providing information to prescribers and patients. In fact, many pharmacists provide drug information as part of the prescribing and medication adherence process, which can often be difficult to source in developing countries. 19 Drug order Medication errors and adverse drug reactions cause many preventable adverse events each year across a range of drug classes. 20,21 Regular pharmacist of medications through clinical drug order s can reduce the risk of medication misadventures and improve patient outcomes. 22,23 European hospitals predominantly offer a centralized pharmacy service in which a pharmacist does not visit the wards on a daily basis. The percentage of hospitals providing a centralized service with a daily ward visit decreased in the 2005 survey; however, the percentage of hospitals offering a decentralized service where pharmacists spend over 50% of their time in the wards increased to almost 10%. 12 However, many developing nations do not have access to pharmacists to routinely provide this service. Am J Health-Syst Pharm Vol 66 Mar 1, 2009 Suppl 3 S31
4 Pharmacists should best evaluate where to expend their effort for optimal results in situations where there is not enough time or resources to visit the wards daily. In many cases, clinical services can be provided remotely, perhaps as a chart. While remote services are not ideal, they provide a low level of pharmaceutical care for the patient within the limited available funding associated with developing countries. Such models can also be used in more affluent nations where small hospitals do not have access to dedicated ward pharmacy services. Computerized prescriber order entry can provide an electronic check of compliance with restrictions but lacks the clinical interpretation provided by a pharmacist in cases that are not clear-cut. While electronic prescribing has been shown to reduce error rates and improve formulary compliance, it generates its own alternative sources for errors, requiring different pharmacist interventions. 24 Participation in patient rounds Pharmacist interventions at the patient level can reduce health care visits, costs, and adverse drug effects. 16 Interventions utilizing written materials demonstrated significant outcome benefits in Indian patients who had a 50% illiteracy rate. 11 European hospitals have an average of five pharmacists and six pharmacy technicians to serve 680 inpatient and 90 day-stay beds per hospital, 12 generating an average of 136 inpatient and 18 day-stay beds per pharmacist. Australian standards recommend no more than 30 medical, 40 surgical, or 50 day-stay beds per pharmacist. 15 Thus, discrepancies exist between developed countries, depending on the service delivery paradigm and focus of pharmacist activities. In 2004, the Australian Health Ministers issued a joint communiqué, agreeing on seven patient safety initiatives for implementation by The two relevant to clinical pharmacy services were (1) use of a common medication chart (this has been achieved) and (2) a documented pharmaceutical process for all medication prescribing, dispensing, and administration (this has not yet been achieved, as debate is continuing over the definition of pharmaceutical and which professions are able to complete one). The range of pharmacist influences on the prescribing process is summarized in Figure 1. Pharmacist prescribing The Global Pharmacy Survey showed very low levels of independent pharmacist prescribing and only slightly higher levels of dependent pharmacist prescribing. This was expected, since pharmacist prescribing in either model is an emerging area of practice. The geographic distribution of pharmacist prescribing models incorporates all areas except North America and Oceania. In the United Kingdom in 2006, 750 supplementary prescriber pharmacists prescribed 23,000 items. Nurses prescribed almost 5.5 million items during the same time period. These prescriptions were written utilizing an agreed protocol model, where additional supplies of a drug originally prescribed by a medical practitioner were prescribed if a patient s monitored values were within agreed-upon limits. 26 Similar agreements occur in the United States within academic medical centers. Furthermore, U.K. pharmacist supplementary prescribers with five or more years of experience can convert to independent prescriber status. 27 Independent pharmacist prescribers can prescribe any licensed medicine (i.e., products with a valid marketing authorization in the United Kingdom) for any medical condition that the pharmacist prescriber believes is within his or her competence, with the exception of all controlled drugs. Similar prescribing rights are available to pharmacists in Alberta, Canada. 28 The influences pharmacists exert on prescribing that are detailed above would be equally applicable, regardless of which health professional actually wrote the prescription. Hence, nonprescribing pharmacists would exert influence on prescribing pharmacists as they would for any other prescriber. It is imperative that the tasks of prescribing and dispensing remain separate. In general, pharmacists who participate in providing primary care to patients perform patient assessment; request necessary laboratory tests; interpret data related to medications; modify medication therapy care plans; provide patient information,, and counseling; document the care provided; identify barriers to patient compliance; participate in multidisciplinary s; resolve issues that may impede access to medication therapies; and communicate with physicians and other health care team members. 29 Writing a prescription is a logical extension of these tasks. 30,31 This is more than the substitution of drugs within a therapeutic class (e.g., changing amlodipine to felodipine) or between brands; however, therapeutic substitution can also reduce physician workload and generate cost savings for the health system. 32 Conclusion Many factors influence prescribing and expand the pharmacist s role from a passive dispenser to an active participant in the therapeutic decision-making team. While one person must write the prescription for a patient based on the team s decision, it becomes less important if that person is a physician, nurse prescriber, or pharmacist prescriber if the entire therapeutic decisionmaking process is incorporated into a team approach. The current thrust for pharmacist prescribing in some S32 Am J Health-Syst Pharm Vol 66 Mar 1, 2009 Suppl 3
5 Figure 1. Pharmacist influences on the prescribing process. Diagnosis made, drug therapy required Which classes of drug are appropriate for the diagnosis? Which single drug class is most appropriate for the patient s clinical situation? Are any drugs from this class available on the formulary? Which single drug from this class is most appropriate for the patient s clinical situation? Is this drug available on the formulary? Determine appropriate route of administration for the patient s clinical situation Is an appropriate formulation available on the formulary? Determine appropriate dose frequency for the patient s clinical situation Determine appropriate duration of therapy for the patient s clinical situation Write the prescription (doctor/pharmacist/ physiotherapist/nurse/ other) Source and supply the drug (logistics) Administration Monitor therapy Participate in Participate in Is an appropriate formulation available on the formulary? Determine appropriate dose &/or concentration Am J Health-Syst Pharm Vol 66 Mar 1, 2009 Suppl 3 S33
6 jurisdictions is suggested as a response to a shortage of physicians. However, there is also a shortage of pharmacists, so this is a selfdefeating argument. Advanced practitioners with suitable postgraduate qualifications could be considered for this role; however, in the majority of countries, a much greater value in terms of improved patient outcomes would be achieved by increasing the role of pharmacists in medicine prescribing. References: 1. Malleck DJ. Professionalism and the boundaries of control: pharmacists, physicians and dangerous substances in Canada, Med Hist. 2004; 48: De Vries T, Henning R, Hogerzeil H et al. Guide to good prescribing. A practical manual. Geneva: World Health Organization; Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007; 27: Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy. 2002; 22: Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999; 19: Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy. 2001; 21: Bond CA, Raehl CL, Patry R. Evidencebased core clinical pharmacy services in United States hospitals in 2020: services and staffing. Pharmacotherapy. 2004; 24: Bond CA, Raehl CL, Pitterle ME et al. Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy. 1999; 19: Dooley MJ, Allen KM, Doecke CJ et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004; 57: Quick JD. Essential medicines twenty-five years on: closing the access gap. Health Policy Plan. 2003; 18: Angunawela II, Diwan VK, Tomson G. Experimental evaluation of the effects of drug information on antibiotic prescribing: a study in outpatient care in an area of Sri Lanka. Int J Epidemiol. 1991; 20: European Association of Hospital Pharmacists. EAHP 2005 survey. eu/eahp-survey (accessed 2008 Aug 7). 13. American Society of Hospital Pharmacists. ASHP guidelines on formulary system management. Am J Hosp Pharm. 1992; 49: Hall K, Tett SE, Nissen LM. Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Med Care. 2006; 44: Committee of Specialty Practice in Clinical Pharmacy. Society of Hospital Pharmacy in Australia Standards of Practice for Clinical Pharmacy. J Pharm Pract Res. 2005; 35: Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000; 3:CD Soumerai SB, Avorn J. Predictors of physician prescribing change in an al experiment to improve medication use. Med Care. 1987; 25: Sabri AA, Qayyum MA. The problem of evidence-based medicine in developing countries. CMAJ. 2006; 175:62. Letter. 19. Udezi WA, Oparah AC, Enyi KU. An investigation of drug information needs of Nigerian pharmacists. Drug Inf J. 2007; 41: Runciman WB, Roughead EE, Semple SJ et al. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003; 15(suppl 1):i Nguyen JK, Fouts MM, Kotabe SE et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother. 2006; 4: Keller RB, Slattum PW. Strategies for prevention of medication-related falls in the elderly. Consult Pharm. 2003; 18: Forster AJ, Halil RB, Tierney MG. Pharmacist surveillance of adverse drug events. Am J Health-Syst Pharm. 2004; 61: Donyai P, O Grady K, Jacklin A et al. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol. 2008; 65: Wahrenberger JW. Prescription drug surival guide. patient/survivalguide.htm (accessed 2008 Aug 26). 26. National Patient Safety Agency. Safety in doses: medication safety incidents in the NHS. London: Patient Safety Observatory; Royal Pharmaceutical Society of Great Britain. Pharmacist prescriber pack. pharmprescriberpack.pdf (accessed 2008 Aug 7). 28. Alberta College of Pharmacists. Additional prescribing authorization. Licensure/Pharmacists.aspx?id=6253 (accessed 2008 Aug 7). 29. Manasse HR Jr, Speedie MK. Pharmacists, pharmaceuticals, and policy issues shaping the work force in pharmacy. Am J Health-Syst Pharm. 2007; 64:e Nguyen NA, Bajorek BV. Pharmacist prescribing in warfarin therapy: exploring clinical utility in the hospital setting. J Pharm Pract Res. 2008; 38: Clarke V. How prescribing in oncology and haematology has led to patient benefit. Pharm J. 2008; 280: Alexander AJ, Gatewood SB. Revealing undetected problems with medication therapy management services. Consult Pharm. 2008; 23: S34 Am J Health-Syst Pharm Vol 66 Mar 1, 2009 Suppl 3
The Pharmacist Coalition for Health Reform
1 As Australian health professionals and policymakers grapple with the pressures and realities of caring for a growing community with changing needs, there s an opportunity to uncover better ways of using
More informationThe Pharmacy Technician Certification
SPECIAL FEATURE Updating the Pharmacy Technician Certification Examination: A practice analysis study PATRICIA M. MUENZEN, MELISSA MURER CORRIGAN, MIRIAM A. MOBLEY SMITH, AND PHARA G. RODRIGUE Am J Health-Syst
More informationOptimizing pharmaceutical care via Health Information Technology:
Optimizing pharmaceutical care via Health Information Technology: The Epic Challenge Rilwan Badamas, PharmD, CAHIMS Pharmacy Grand Rounds 01/03/2017 2011 MFMER slide-1 The medication management team requests
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationPharmaceutical Services Report to Joint Conference Committee September 2010
Pharmaceutical Services Report to Joint Conference Committee September 21 Background: Pharmaceutical Services staffing has increased by 31 FTE from 26 due to program changes and to comply with regulatory
More informationExperiential Education
Experiential Education Experiential Education Page 1 Experiential Education Contents Introduction to Experiential Education... 3 Experiential Education Calendar... 4 Selected ACPE Standards 2007... 5 Standard
More information4/2/2018. Objectives. Victoria Stanislovaitis, PharmD. Medication Reconciliation (Med Rec) Victoria M. Stanislovaitis, PharmD. RockMED LTC Pharmacy
Medication Reconciliation (Med Rec) Victoria M. Stanislovaitis, PharmD RockMED LTC Pharmacy Objectives Definitions Explain the importance of medication reconciliation Learn the duties and responsibilities
More informationLiterature review: pharmaceutical services for prisoners
Author: Rosemary Allgeier, Principal Pharmacist in Public Health. Date: 08 October 2012 Version: 1a Publication and distribution: NHS Wales (intranet and internet) Public Health Wales (intranet and internet)
More informationThe Mirror to Hospital Pharmacy
Fifty years of advancement in American hospital pharmacy Douglas J. Scheckelhoff ar Layar The Mirror to Hospital Pharmacy not only served an important role in assessing the state of pharmacy practice in
More informationREVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY
REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY Approved September 2014, Bangkok, Thailand, as revisions of the initial 2008 version. Overarching and Governance Statements 1. The overarching
More informationChapter 13. Documenting Clinical Activities
Chapter 13. Documenting Clinical Activities INTRODUCTION Documenting clinical activities is required for one or more of the following: clinical care of individual patients -sharing information with other
More informationJournal of Pharmacy Practice and Community Medicine.2017, 3(4s):S61-S66
Journal of Pharmacy Practice and Community Medicine.2017, 3(4s):S61-S66 http://dx.doi.org/10.5530/jppcm.2017.4s.50 RESEARCH ARTICLE OPEN ACCESS Pharmacy Workload and Workforce Requirements at MOH Primary
More informationPractice of Hospital Pharmacy in Bangladesh: Current Perspective
Bangladesh Pharmaceutical Journal 17(2): 187-192, 2014 Practice of Hospital Pharmacy in Bangladesh: Current Perspective Tripti Rani Paul 1, Md.Ajijur Rahman 2, Mohitosh Biswas 2, Mamunur Rashid 2 and Md.
More informationDisclosure. SwedishAmerican Hospital A Division of UW Health. Learning Objectives. Medication History. Medication History 2/2/2017
Disclosure Pharmacy Technician- Acquired Medication Histories in the ED: A Path to Higher Quality of Care David Huhtelin, PharmD Emergency Medicine Clinical Pharmacist SwedishAmerican Hospital A Division
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable
More informationguide AUGUST 2017 for Pharmacist Salary Banding
guide AUGUST 2017 for Pharmacist Salary Banding in New Zealand Pharmacist Salary Banding introduction The Pharmaceutical Society of New Zealand has produced this guide to provide a national remuneration
More informationJournal of Pharmacy Practice and Community Medicine.2017, 3(4s):S95-S100
Journal of Pharmacy Practice and Community Medicine.2017, 3(4s):S95-S100 http://dx.doi.org/10.5530/jppcm.2017.4s.55 RESEARCH ARTICLE OPEN ACCESS Pharmacy Technician Workload and Workforce Requirements
More informationMedication Management: Is It in Your Toolbox?
Medication Management: Is It in Your Toolbox? Brian K. Esterly, MBA, SVP, Corporate Development, excellerx, Inc. O: 215.282.1676, besterly@excellerx.com What has been your Medication Management experience?
More informationHospital Self Assessment Worksheet
DESCRIPTION AND INSTRUCTIONS This worksheet consists of 106 questions assessing adoption of the Hospital Self- Assessment recommendations at the hospital level. These recommendations were based on the
More informationComparison on Human Resource Requirement between Manual and Automated Dispensing Systems
VALUE IN HEALTH REGIONAL ISSUES 12C (2017) 107 111 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/vhri Comparison on Human Resource Requirement between Manual and Automated
More informationClinical Pharmacy Services
Clinical Pharmacy Services Jean-François Bussières Introduction Pharmacists react strongly to those film clips intended to illustrate the practice of pharmacy, featuring a close-up of a hand counting out
More informationNon-Medical Prescribing Passport. Reflective Log And Information
Non-Medical Prescribing Passport Reflective Log And Information Non-Medical Prescribing Continued Profession Development Log NMPs must refer to their regulatory bodies requirements for maintaining and
More informationEXPERIENTIAL EDUCATION Medication Therapy Management Services Provided by Student Pharmacists
EXPERIENTIAL EDUCATION Medication Therapy Management Services Provided by Student Pharmacists Micah Hata, PharmD, a Roger Klotz, BSPharm, a Rick Sylvies, PharmD, b Karl Hess, PharmD, a Emmanuelle Schwartzman,
More informationAdverse Drug Events and Readmissions: The Global Picture
Adverse Drug Events and Readmissions: The Global Picture Kyle E. Hultgren, PharmD Managing Director Center for Medication Safety Advancement Purdue University College of Pharmacy Indianapolis, IN 4 Learning
More informationW e were aware that optimising medication management
207 QUALITY IMPROVEMENT REPORT Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds M Fertleman, N Barnett, T Patel... See end of article for authors affiliations...
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationCLINICAL PRIVILEGE WHITE PAPER
Practice area 183 CLINICAL PRIVILEGE WHITE PAPER Hospital pharmacist Background Hospital pharmacists promote appropriate, effective, and safe medication use for patients within the hospital. By working
More informationIntroduction of EPMA in paediatric practice in UK:
Introduction of EPMA in paediatric practice in UK: REALISING THE CLINICAL BENEFITS AND ENGAGING CLINICAL STAFF Stephen Marks Consultant Paediatric Nephrologist and EPMA lead Great Ormond Street Hospital
More informationThe Royal Flying Pharmacist? New Solutions in Rural Health
The Royal Flying Pharmacist? New Solutions in Rural Health Roy S Packer 4 th Year BPharm Student James Cook University School of Pharmacy Angus Smith Dr, James Cook University QLD 4811, Australia roy.packer@jcu.edu.au
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More informationBringing the Clinical Mindset to the Retail Pharmacist
Bringing the Clinical Mindset to the Retail Pharmacist Sarah Griffin, Pharm.D. Harding University College of Pharmacy White County Medical Center Objectives Describe challenging situations faced by pharmacists
More informationStephen C. Joseph, M.D., M.P.H.
JUL 26 1995 MEMORANDUM FOR: ASSISTANT SECRETARY OF THE ARMY (MANPOWER & RESERVE AFFAIRS) ASSISTANT SECRETARY OF THE NAVY (MANPOWER & RESERVE AFFAIRS) ASSISTANT SECRETARY OF THE AIR FORCE (MANPOWER, RESERVE
More informationProfessional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.
Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7
More informationPrimary Care Center Pharmacist s Workforce in Eleven-Year at Ministry of Health in Saudi Arabia
REEARCH ARTICLE OPEN ACCE Journal of Pharmacy Practice and Community edicine., (s):- http://dx.doi.org/./jppcm..s. Primary Care Center Pharmacist s Workforce in Eleven-Year - at inistry of Health in audi
More informationPOLICY BRIEF. Identifying Adverse Drug Events in Rural Hospitals: An Eight-State Study. May rhrc.umn.edu. Background.
POLICY BRIEF Identifying Adverse Drug Events in Rural Hospitals: An Eight-State Study Michelle Casey, MS Peiyin Hung, MSPH Emma Distel, MPH Shailendra Prasad, MBBS, MPH Key Findings In 2013, Critical Access
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationASHP Guidelines: Minimum Standard for Pharmaceutical Services in Ambulatory Care
428 Practice Settings Guidelines ASHP Guidelines: Minimum Standard for Pharmaceutical Services in Ambulatory Care In recent years there has been an increasing emphasis in health care on the provision of
More informationEVALUATION OF THE FINANCIAL IMPACT OF MEDICATION BACKORDERS IN A TERTIARY CARE HOSPITAL. Kalyn Marie Acker
EVALUATION OF THE FINANCIAL IMPACT OF MEDICATION BACKORDERS IN A TERTIARY CARE HOSPITAL by Kalyn Marie Acker PharmD, University of Texas at Austin, 2015 BS in Biochemistry, Texas Tech University, 2011
More informationD DRUG DISTRIBUTION SYSTEMS
D DRUG DISTRIBUTION SYSTEMS JANET HARDING ORAL MEDICATION SYSTEMS Drug distribution systems in the hospital setting should ideally prevent medication errors from occurring. When errors do occur, the system
More informationI CSHP 2015 CAROLYN BORNSTEIN
I CSHP 2015 CAROLYN BORNSTEIN CSHP 2015 is a quality initiative of the Canadian Society of Hospital Pharmacists that describes a preferred vision for pharmacy practice in the hospital setting by the year
More informationASHP Guidelines: Minimum Standard for Ambulatory Care Pharmacy Practice
Practice Settings Guidelines 535 ASHP Guidelines: Minimum Standard for Ambulatory Care Pharmacy Practice In recent years, there has been an increasing emphasis in health systems on the provision of ambulatory
More informationWhat is prescribing? Proposal. Non-Medical Prescribing. 4 Domains of Prescribing. Mapping the 4 Domains of Prescribing.
Non-Medical Charles Mitchell What is prescribing? Director CSEP, University of Queensland Senior Medical Advisor, MSQ, QH Proposal should be considered in a similar way to procedures Where a combination
More informationPharmacy Management. 450 Pharmacy Management Positions
450 Pharmacy Management Positions Pharmacy Management Disposition of Illicit Substances (1522) To advocate that healthcare organizations be required to develop procedures for the disposition of illicit
More informationWho Cares About Medication Reconciliation? American Pharmacists Association American Society of Health-system Pharmacists The Joint Commission Agency
The Impact of Medication Reconciliation Jeffrey W. Gower Pharmacy Resident Saint Alphonsus Regional Medical Center Objectives Understand the definition and components of effective medication reconciliation
More informationLiberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making
Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Royal Pharmaceutical Society response The Royal Pharmaceutical Society (RPS) is the professional
More informationPharmacy Technicians and Interns: Charting New Territory
Pharmacy Technicians and Interns: Charting New Territory Peter Dippel Pharm.D, BCPS Clinical Pharmacist II Baptist Health Medical Center NLR Objectives Understand what Pharmacist Extenders are and why
More informationSection Title. Prescribing competency framework Catherine Picton, Lead author
Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to
More informationColorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements
6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services
More informationPharmacy Operations. General Prescription Duties. Pharmacy Technician Training Systems Passassured, LLC
Pharmacy Operations General Prescription Duties Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, General Prescription Duties PassAssured's Pharmacy Technician Training Program
More informationPHCY 471 Community IPPE. Student Name. Supervising Preceptor Name(s)
PRECEPTOR CHECKLIST /SIGN-OFF PHCY 471 Community IPPE Student Name Supervising Name(s) INSTRUCTIONS The following table outlines the primary learning goals and activities for the Community IPPE. Each student
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationImproving Clinical Outcomes
Improving clinical outcomes and reducing health care costs under the Affordable Care Act - are enhanced medication management strategies part of the solution? Sandra L. Baldinger, Pharm.D., M.S. Kenneth
More informationTackling the challenge of non-adherence
Tackling the challenge of non-adherence 2 How is adherence defined? WHO definition: the extent to which a person s behaviour taking medication, following a diet and/or executing lifestyle changes corresponds
More informationUnderstanding Antimicrobial Stewardship: Is Your Organization Ready? A S H LEIGH MOUSER, PHARM D, BCPS
Understanding Antimicrobial Stewardship: Is Your Organization Ready? A S H LEIGH MOUSER, PHARM D, BCPS Objectives Discuss the need for antimicrobial stewardship programs Explain the components of an effective
More informationAm J Health-Syst Pharm. 2009; 66(Suppl 3):S56-60
64. Council of Europe. Expert Group on Safe Medication Practices. Creation of a better medication safety culture in Europe: building up safe medication practices. www.coe.int/t/e/social_cohesion/soc-sp/
More informationBulletin Independent prescribing information for NHS Wales
Bulletin Independent prescribing information for NHS Wales Medicines-related admissions February 2015 Although medicines play an important role in the management of chronic and acute illnesses, they can
More informationPharmacy Technician Education, Training and Competency:
Pharmacy Technician Education, Training and Competency: A position statement for the Minnesota Society of Health System Pharmacists (MSHP) on recommended changes for pharmacy technicians. May 22, 2007
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More informationMEDICATION THERAPY MANAGEMENT. MemberChoice FORMULARY MANAGEMENT MEDICATION THERAPY MANAGEMENT (MTM) SPECIALTY DRUG MANAGEMENT
MemberChoice FORMULARY MANAGEMENT MEDICATION THERAPY MANAGEMENT (MTM) SPECIALTY DRUG MANAGEMENT MEDICATION THERAPY MANAGEMENT Medication Therapy Management 1 $ 290 Billion Wasted in avoidable costs due
More informationPrepared Jointly by the American Society of Health-System Pharmacists and the Academy of Managed Care Pharmacy
Required and Elective Educational Outcomes, Educational Goals, Educational Objectives, and Instructional Objectives for Postgraduate Year One (PGY1) Managed Care Pharmacy Residency Programs Prepared Jointly
More informationNHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)
SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED
More informationEvaluation of Cart Fill Drug Distribution System for In-patients at a South Indian Tertiary Care Teaching Hospital
Review Article Evaluation of Cart Fill Drug Distribution System for In-patients at a South Indian Tertiary Care Teaching Hospital Dilna Raveendran, Adepu Ramesh*, Justin Kurian Department of Pharmacy Practice,
More informationThe TTO Journey: How Much Of It Is Actually In Pharmacy?
The TTO Journey: How Much Of It Is Actually In Pharmacy? Green CF 1,2, Hunter L 1, Jones L 1, Morris K 1. 1. Pharmacy Department, Countess of Chester Hospital NHS Foundation Trust. 2. School of Pharmacy
More informationLicensed Pharmacy Technicians Scope of Practice
Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationUKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
More informationPresentation Outline
Pharmacist Practice Expectations Weighing Value and Setting Priorities Nick Honcharik, Pharm. D. Presentation Outline Pharmacist Practice Expectations Background/rationale Development Selective examples
More informationBackground and Methodology
Study Sites and Investigators Emergency Department Pharmacists Improve Patient Safety: Results of a Multicenter Study Supported by the ASHP Foundation Jeffrey Rothschild, MD, MPH-Principal Investigator
More informationNew v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee
Clinical Pharmacy Services: SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key Words:
More informationCHAPTER 19 THE FORMULARY SYSTEM
CHAPTER 19 THE FORMULARY SYSTEM 19.1 Formulary System In the Nursing Home I. OTC Formulary for Medicaid Residents (Patient Care Formulary) 1. OTC medications must be available for Medicaid residents. 2.
More informationCASE STUDY ON THE MANAGEMENT OF MEDICATION ERRORS AND NEAR MISSES: MALAYSIA PERSPECTIVE
CASE STUDY ON THE MANAGEMENT OF MEDICATION ERRORS AND NEAR MISSES: MALAYSIA PERSPECTIVE AR Abdul Aziz PhD;Law CL;Nor Safina AM KPJ HEALTHCARE BERHAD Abstract: Hospital A is a private hospital in Malaysia
More informationThe Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System
The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System Scott R. Smith, MSPH, PhD Center for Outcomes & Evidence Agency for Healthcare Research & Quality July 20,
More informationEvaluation of case write-up: Assessment of prescription writing skills of fifth year medical students at UKM Medical Centre
Available online at www.sciencedirect.com Procedia - Social and Behavioral Sciences 60 ( 2012 ) 249 253 UKM Teaching and Learning Congress 2011 Evaluation of case write-up: Assessment of prescription writing
More informationEuropean Association of Hospital Pharmacists (EAHP)
European Association of Hospital Pharmacists (EAHP) Consultation Response Delegated Act on the detailed rules for a unique identifier for medicinal products for human use, and its verification. April 2012
More informationValue Added Medicines Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access
Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access 09 June 2016 Pr. Mondher Toumi M.D., MSc., Ph.D. Professor in Public Health Department Research Unit EA 3279, Aix-Marseille University
More informationPharmaceutical Care A case study of Connaught Hospital
International Journal of Scientific and Research Publications, Volume 7, Issue 7, July 2017 731 Pharmaceutical Care A case study of Connaught Hospital Brian S. Thompson *, Prof. A.C Oparah ** * Dept. of
More informationDrug Shortage Preparedness
PURDUE UNIVERSITY COLLEGE OF PHARMACY S CENTER FOR MEDICATION SAFETY ADVANCEMENT Drug Shortage Preparedness Survey and Tips for Improvement Developed by: Jonathan Weir, PharmD Candidate in collaboration
More informationJMSCR Vol 3 Issue 10 Page October 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v3i10.55 A Survey on Awareness about Pharmacovigilance among Community Pharmacists
More informationPerformance Measurement of a Pharmacist-Directed Anticoagulation Management Service
Hospital Pharmacy Volume 36, Number 11, pp 1164 1169 2001 Facts and Comparisons PEER-REVIEWED ARTICLE Performance Measurement of a Pharmacist-Directed Anticoagulation Management Service Jon C. Schommer,
More informationDESIGNATED PRESCRIBING AUTHORITY FOR REGISTERED NURSES WORKING IN PRIMARY HEALTH AND SPECIALTY TEAMS
In Confidence Office of the Minister of Health Cabinet Social Policy Committee DESIGNATED PRESCRIBING AUTHORITY FOR REGISTERED NURSES WORKING IN PRIMARY HEALTH AND SPECIALTY TEAMS Proposal 1. I propose
More informationThe extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia
LITERATURE REVIEW The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia Elizabeth E. Roughead BPharm, DipHlthProm, MAppSc, PhD, Susan J. Semple
More informationClinical Pharmacy Practice Models
Disclosure Clinical Pharmacy Practice Models in Oncology Patient Care Rachel Matthews, PharmD, BCOP I have no actual or potential conflict of interest in relation to this program/presentation. Objectives
More informationAnnexure A COMPETENCE STANDARDS FOR CPD INTRODUCTION
COMPETENCE STANDARDS FOR CPD INTRODUCTION Pharmacists in each field of practice need to accept responsibility for the selfassessment and maintenance of their competence throughout their professional lives.
More informationSafer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the
More informationEuropean Commission consultation on measures for improving the recognition of medical prescriptions issued in another member state
European Commission consultation on measures for improving the recognition of medical prescriptions issued in another member state NHS European Office response The National Health Service (NHS) is one
More informationAPPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION
APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION This joint statement was developed by the CMA and the Canadian Pharmaceutical
More informationWhat are the potential ethical issues to be considered for the research participants and
What are the potential ethical issues to be considered for the research participants and researchers in the following types of studies? 1. Postal questionnaires 2. Focus groups 3. One to one qualitative
More informationImproving patient safety and infection. Patient Safety Forum Dr J Coleman 1 ELECTRONIC PRESCRIBING AND CLINICAL DECISION SUPPORT (CDS)
Improving Patient Safety and Infection Control Through Electronic Prescribing Dr Jamie Coleman Senior Lecturer in Clinical Pharmacology / Honorary Consultant Physician The brief Clinical computing technologies
More informationContext. Objectives. Hospital-based Pharmacy and Therapeutics Committees: Evolving Responsibilities and Membership
Issue 23 July 2011 Hospital-based Pharmacy and Therapeutics Committees: Evolving Responsibilities and Membership Context In this report, the term Pharmacy and Therapeutics Committee () refers to a committee
More informationFoundation Pharmacy Framework
Association of Pharmacy Technicians UK Foundation Pharmacy Framework A framework for professional development in foundation across pharmacy APTUK Foundation Pharmacy Framework The Professional Leadership
More informationImplementation of Telepharmacy in Rural Hospitals: Potential for Improving Medication Safety
Upper Midwest Rural Health Research Center uppermidwestrhrc.org POLICY BRIEF March 2009 Implementation of Telepharmacy in Rural Hospitals: Potential for Improving Medication Safety Key Findings Although
More informationPharmacy Department PRE-REGISTRATION TRAINEE PHARMACIST INFORMATION PACK
Pharmacy Department PRE-REGISTRATION TRAINEE PHARMACIST INFORMATION PACK 2 INDEX 1. Chelsea and Westminster Hospital 3 2. The Pharmacy 3 3. Services 3 4. Education and Training 5 5. Miscellaneous 5.1 Social
More informationPolicies Approved by the 2017 ASHP House of Delegates
House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare
More informationC DRUG DISTRIBUTION SYSTEMS
C DRUG DISTRIBUTION SYSTEMS JANET HARDING ORAL MEDICATION SYSTEMS Hospital pharmacy departments are expected to operate drug distribution systems which are safe for the patient, efficient and economical,
More informationMedication Adherence
Medication Adherence Robert DiGregorio, PharmD, FNAP, BCACP Professor (Long Island University) Sr. Director, Pharmacy & Pharmacotherapy Services (TBHC) Chief, Pharmacotherapy Department of Internal Medicine
More informationH2H Mind Your Meds "Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome
H2H Mind Your Meds "Challenge Webinar #3- Lessons Learned Wednesday, April 18, 2012 2:00 pm 3:00 pm ET 1 Welcome Take Home Messages Understand how to implement the Mind Your Meds strategies and tools in
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationMost of you flew to this meeting
Most of you flew to this meeting on an airplane and, like me, ignored the flight attendant asking you to pay attention and listen to a few safety warnings that were being offered. In spite of having listened,
More informationELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES
ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES Introduction The competency areas, goals, and objectives are for use with the ASHP Accreditation Standard
More informationPharmacists in Transitions of Care: We Can All Make a Difference
Pharmacists in Transitions of Care: We Can All Make a Difference Disclosure The speakers of this panel have no actual or potential conflict of interest in relation to this program to disclose. Kenda Germain,
More informationPharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02
Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02 V02 issued Issue 1 May 11 Issue 2 Dec 11 Planned review May
More information